Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?

Since mesenchymal stromal/stem cells (MSCs) were discovered, researchers have been drawn to study their peculiar biological features, including their immune privileged status and their capacity to selectively migrate into inflammatory areas, including tumors. These properties make MSCs promising cel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Giulia Golinelli, Ilenia Mastrolia, Beatrice Aramini, Valentina Masciale, Massimo Pinelli, Lucrezia Pacchioni, Giulia Casari, Massimiliano Dall’Ora, Milena Botelho Pereira Soares, Patrícia Kauanna Fonseca Damasceno, Daniela Nascimento Silva, Massimo Dominici, Giulia Grisendi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020-09-01
Sarja:Frontiers in Pharmacology
Aiheet:
mesenchymal stromal/stem cell
cancer
tumor necrosis factor-related apoptosis-inducing ligand
gene therapy
cell therapy
Linkit:https://www.frontiersin.org/article/10.3389/fphar.2020.529921/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia